1099

Sinopharm Group Co. Ltd. Stock Price

SEHK:1099 Community·HK$60.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

1099 Share Price Performance

HK$19.34
-0.71 (-3.54%)
HK$19.34
-0.71 (-3.54%)
Price HK$19.34

1099 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Undervalued with excellent balance sheet and pays a dividend.

2 Risks
4 Rewards

Sinopharm Group Co. Ltd. Key Details

CN¥583.2b

Revenue

CN¥538.9b

Cost of Revenue

CN¥44.2b

Gross Profit

CN¥37.3b

Other Expenses

CN¥6.9b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
2.22
7.59%
1.19%
72.1%
View Full Analysis

About 1099

Founded
2003
Employees
108217
CEO
Wanyong Lian
WebsiteView website
www.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. The company was founded in 2003 and is headquartered in Shanghai, the People’s Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Recent 1099 News & Updates

Sinopharm Group Co. Ltd. (HKG:1099) Shares Could Be 23% Below Their Intrinsic Value Estimate

Oct 28
Sinopharm Group Co. Ltd. (HKG:1099) Shares Could Be 23% Below Their Intrinsic Value Estimate

Recent updates

No updates